This activity is expired and is no longer available for CME credit.


Breakthroughs in the Treatment of Bladder Cancer

Author(s)/Faculty: Leonard Gomella, MD
Release Date: 12/14/2016Expiration Date: 12/13/2017
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant enhancements to clinical outcomes. With multiple ongoing clinical trials evaluating the efficacy and safety of recently approved or late-stage checkpoint blockade inhibitors, it is imperative that oncologists and urologists who treat patients with bladder cancer are kept abreast of emerging data and of the potential impact of these novel therapies to clinical outcomes. Within this CME activity, Dr. Leonard G. Gomella discusses the role of immunotherapy in bladder cancer and evaluates recently reported breakthroughs in the treatment of bladder cancer.